95 related articles for article (PubMed ID: 16447733)
1. [Retrovirus infection and neurological disorders].
Izumo S
Rinsho Shinkeigaku; 2005 Nov; 45(11):815-7. PubMed ID: 16447733
[TBL] [Abstract][Full Text] [Related]
2. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
[TBL] [Abstract][Full Text] [Related]
3. [Retrovirus infection and neurological disorders].
Izumo S; Kubota R; Xing HQ
No To Shinkei; 2006 Jul; 58(7):595-604. PubMed ID: 16910468
[No Abstract] [Full Text] [Related]
4. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
Carod-Artal FJ
Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
[TBL] [Abstract][Full Text] [Related]
5. In vitro cytoskeleton changes of mouse neurons induced by purified HTLV-1, and PBMC from HAM/TSP patients and HTLV-1 carriers.
Ramirez E; Cartier L; Flores R
Arch Virol; 2004 Dec; 149(12):2307-17. PubMed ID: 15338322
[TBL] [Abstract][Full Text] [Related]
6. High production of RANTES and MIP-1alpha in the tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
Montanheiro P; Vergara MP; Smid J; da Silva Duarte AJ; de Oliveira AC; Casseb J
J Neuroimmunol; 2007 Aug; 188(1-2):138-42. PubMed ID: 17588676
[TBL] [Abstract][Full Text] [Related]
7. Localization of retrovirus in the central nervous system of a patient co-infected with HTLV-1 and HIV with HAM/TSP and HIV-associated dementia.
Levin MC; Rosenblum MK; Fox CH; Jacobson S
J Neurovirol; 2001 Feb; 7(1):61-5. PubMed ID: 11519484
[TBL] [Abstract][Full Text] [Related]
8. Human T-cell lymphotropic virus type I (HTLV-I) confirmed by PCR-Southern blot and sequencing analysis in a woman with tropical spastic paraparesis.
Perandin F; Cariani A; Bonfanti C; Trainini L; Magoni M; Manca N
Neurol Sci; 2006 Sep; 27(4):257-60. PubMed ID: 16998729
[TBL] [Abstract][Full Text] [Related]
9. Neuropathology of HTLV-1-associated myelopathy (HAM/TSP): The 50th Anniversary of Japanese Society of Neuropathology.
Izumo S
Neuropathology; 2010 Oct; 30(5):480-5. PubMed ID: 20573027
[TBL] [Abstract][Full Text] [Related]
10. [Rat model of HTLV-I infection--ultrastructural study of HAM rat disease].
Abe M
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1399-408. PubMed ID: 7705750
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
[TBL] [Abstract][Full Text] [Related]
12. The peripheral nervous system complications of HTLV-1 myelopathy (HAM/TSP) syndromes.
Grindstaff P; Gruener G
Semin Neurol; 2005 Sep; 25(3):315-27. PubMed ID: 16170744
[TBL] [Abstract][Full Text] [Related]
13. [Neurological symptoms and disability in HTLV-1 associated myelopathy].
Carod-Artal FJ; Mesquita HM; Ribeiro Lda S
Neurologia; 2008 Mar; 23(2):78-84. PubMed ID: 18322825
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of CD4+T cells expressing fractalkine receptor CX3CR1 in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), but its AIDS susceptible polymorphisms are not associated with the disease.
Saito M; Usuku K; Arimura K; Izumo S; Osame M; Ohara Y
J Neurol Sci; 2008 Mar; 266(1-2):13-9. PubMed ID: 17884099
[TBL] [Abstract][Full Text] [Related]
16. [In situ PCR detection of HTLV-1 provirus in spinal cord lesions with HAM/TSP].
Izumo S; Kashio N; Hashimoto K; Osame M
Tanpakushitsu Kakusan Koso; 1996 Apr; 41(5):656-9. PubMed ID: 8650359
[No Abstract] [Full Text] [Related]
17. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.
Silva MT; Harab RC; Leite AC; Schor D; Araújo A; Andrada-Serpa MJ
Clin Infect Dis; 2007 Mar; 44(5):689-92. PubMed ID: 17278060
[TBL] [Abstract][Full Text] [Related]
18. HTLV-I production based on activation of integrin/ligand signaling in HTLV-I-infected T cell lines derived from HAM/TSP patients.
Fukushima N; Nakamura T; Nishiura Y; Ida H; Aramaki T; Eguchi K
Intervirology; 2008; 51(2):123-9. PubMed ID: 18552504
[TBL] [Abstract][Full Text] [Related]
19. HTLV-I-associated myelopathy.
Izumo S; Umehara F; Osame M
Neuropathology; 2000 Sep; 20 Suppl():S65-8. PubMed ID: 11037191
[TBL] [Abstract][Full Text] [Related]
20. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
Montanheiro PA; Penalva de Oliveira AC; Smid J; Fukumori LM; Olah I; da S Duarte AJ; Casseb J
Scand J Immunol; 2009 Oct; 70(4):403-7. PubMed ID: 19751276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
